Patents expiring in 2030

US 7807689

Dipeptidyl peptidase inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7807651

Methods and materials for pain management

The Board of Regents of the University of Texas System · Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7807781

Inhibitors of serine protease activity and their use in methods and compositions for treatment of viral infections

The Regents of the University of Colorado · Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7807787

NELL-1 peptide

The Regents of the University of California · Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7811563

Anti-addl antibodies and uses thereof

Northwestern University · Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7811603

Microfluidic device for forming monodisperse lipoplexes

The Regents of the University of California · Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7811622

Coated implantable medical device

Cook Regentec LLC · Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7811998

Novobiocin analogues as anticancer agents

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7812174

Methods of preparing imidazole-based compounds

LEXICON PHARMACEUTICALS, INC. · Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7812025

Brain/neuronal cell-protecting agent and therapeutic agent for sleep disorder

Takeda Pharmaceutical Company Limited · Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7811592

Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of Chlamydia

The Board of Regents of the University of Texas System · Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7812029

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

Rigel Pharmaceuticals, Inc. · Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7812044

Anticancer agents

Takeda Pharmaceutical Company Limited · Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7811996

Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection

The Regents of the University of California · Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7812168

Purification of montelukast

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7812117

Vasostatin as marrow protectant

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7812199

Hydroxyl compounds and compositions for cholesterol management and related uses

Esperion Therapeutics, Inc. · Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7812150

RNAi modulation of Aha and therapeutic uses thereof

Alnylam Pharmaceuticals, Inc. · Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7812132

Modified vitamin K-dependent polypeptides

Regents of the University of Minnesota · Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7811297

Actuable structures and methods of fabrication and use

TELEDYNE SCIENTIFIC & IMAGING, LLC · Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7811550

Method for making magnetic fluorescent core shell nanoparticles

United States of America as represented by the Secretary of the Air Force · Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7811602

Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof

Tekmira Pharmaceuticals Corporation · Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

DO P2009000148

DERIVADOS DE ESTER Y AMIDA DE INDAZOLILO PARA EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR UN RECEPTOR DE GLUCOCORTICOIDES

BAYER SCHERING PHARMA AG [DE] · Granted Fri Oct 15 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Oct 10 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7816086

Genes of an otitis media isolate of nontypeable Haemophilus influenzae

The Board of Regents of the University of Oklahoma · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7815914

Methods for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7815935

Orally distintegrating formulation and process for preparing the same

Quantum Hi-Tech (Beijing) Research Institute · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7816372

6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds

Ligand Pharmaceuticals Incorporated · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7815916

Cloning and expression of HTLV-III DNA

The United States of America, as represented by the Secretary, Health and Human Services · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7815908

Methods and compositions for treating and preventing disease associated with αVβ5 integrin

The Regents of the University of California · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7815942

Rasagiline formulations of improved content uniformity

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7816075

Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents

Xenon Pharmaceuticals Inc. · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7816076

Therapeutic targets in cancer

Sagres Discovery, Inc. · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7816087

Gene expressed in prostate cancer and methods of use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7816131

Cancer specific promoters

The Board of Regents of the University of Texas System · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7816097

Nucleotide and protein sequence of Mammastatin and methods of use

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7816324

Composition and method for the treatment of diseases affected by a peptide receptor

The Board of Regents of the University of Texas System · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7816529

Pyrimidines useful as modulators of voltage-gated ion channels

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7815434

Dental coating kit

Kuraray Medical Inc. · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7816352

Apoptosis inhibitors

The Regents of the University of California · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7816538

Dimeric small molecule potentiators of apoptosis

The Board of Regents of the University of Texas System · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7816560

Long chain n-alkyl compounds and oxa-derivatives thereof

United Therapeutics Corporation · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7815921

Cytocapacity test for the prediction of the hematopoietic recovery, neutropenic fever, and antimicrobial treatment following high-dose cytotoxic chemotherapy

Ludwig-Maximilians-Universitat Munchen · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7816532

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2010267717

Novel Heterocyclic NF-kB Inhibitors

4SC AG [DE] · Granted Thu Oct 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Oct 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7820733

Dental polymerizable core build-up material of separately packed type

Kuraray Medical Inc. · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7820154

Use of IL-1 antagonists to treat gout

REGENERON PHARMACEUTICALS, INC. · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7820395

Orientia tsutsugamushi truncated recombinant outer membrane protein (R47) and (R56) vaccines diagnostics and therapeutics for scrub typhus

United States of America as represented by the Secretary of the Air Force · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7820631

Anti-viral pyrimidine nucleoside analogues

University College Cardiff Consultants Limited · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)